KEW Stock Overview
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Kewaunee Scientific Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$28.20 |
52 Week High | US$28.80 |
52 Week Low | US$12.40 |
Beta | 0.67 |
1 Month Change | 11.02% |
3 Month Change | 33.02% |
1 Year Change | 108.89% |
3 Year Change | 183.42% |
5 Year Change | n/a |
Change since IPO | 168.57% |
Recent News & Updates
Recent updates
Shareholder Returns
KEW | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 2.9% | -1.0% | 1.4% |
1Y | 108.9% | 4.5% | 7.5% |
Return vs Industry: KEW exceeded the German Medical Equipment industry which returned 3.7% over the past year.
Return vs Market: KEW exceeded the German Market which returned 5.5% over the past year.
Price Volatility
KEW volatility | |
---|---|
KEW Average Weekly Movement | 6.6% |
Medical Equipment Industry Average Movement | 4.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: KEW's share price has been volatile over the past 3 months.
Volatility Over Time: KEW's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1906 | 982 | Thomas Hull | https://www.kewaunee.com |
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Kewaunee Scientific Corporation Fundamentals Summary
KEW fundamental statistics | |
---|---|
Market cap | €85.41m |
Earnings (TTM) | €8.08m |
Revenue (TTM) | €186.04m |
10.6x
P/E Ratio0.5x
P/S RatioIs KEW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KEW income statement (TTM) | |
---|---|
Revenue | US$201.04m |
Cost of Revenue | US$153.27m |
Gross Profit | US$47.77m |
Other Expenses | US$39.04m |
Earnings | US$8.73m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 3.04 |
Gross Margin | 23.76% |
Net Profit Margin | 4.34% |
Debt/Equity Ratio | 69.4% |
How did KEW perform over the long term?
See historical performance and comparison